Fermatex Invests in Fluoropolymer Extrusion Technology

Meeting Customer Needs with Expanded Capabilities

WALL, NEW JERSEY (May 15, 2018) — Fermatex Vascular Technologies Inc. (formerly Gore-Jersey Shore and most notably Adam Spence Corporation), a supplier of reinforced medical tubing and catheter subassemblies, has recently expanded its fluoropolymer extrusion capabilities following industry trends and customer needs.

“We have been receiving an increasing number of inquiries for fluoropolymer micro medical tubing,” Katie Rafferty, Business Development Manager at Fermatex said. “Expanding our existing fluoropolymer extrusion capabilities, which include co-extruded tubing and FEP sheath extrusions, allows us to better meet the increasing number of inquiries. This recent investment includes an upgrade to our American Kuhne high temperature extruder with special corrosion-resistant screw and barrel for processing fluoropolymers along with a new spiral flow crosshead die made from Inconel.” The upgrade will allow Fermatex to offer micro-bore and thin-wall fluoropolymer tubing.

In addition to fluoropolymers, Fermatex processes other high temperature polymers that are not corrosive such as PEEK, Polysulfone (PSU), and Polyetherimide (PEI). Value added services include tipping, flaring, and hole processing. Fermatex is exhibiting at MD&M East in New York City, June 12 to 14, 2018.

About Fermatex Vascular Technologies

Fermatex designs and manufactures highly engineered medical extrusions, braid reinforced tubing and catheter sub-assemblies for many of the world’s leading medical device OEMS. Originally founded as Adam Spence Corporation in 1960, the Company was acquired by WL Gore in 2004 and sold to Vance Street Capital in 2017. The company was a pioneer in the contract design and manufacture of medical devices and has been providing extrusions to medical device industry for over 55 years. www.fermatex.com.

About Vance Street Capital LLC

Vance Street Capital is a Los Angeles-based private equity firm, which invests in middle-market businesses in the medical, aerospace, defense and industrial sectors. For over two decades, Vance Street’s partners have worked with management, family owners and other co-investors to accelerate revenue growth, improve operations and acquire strategic assets for the companies in their investment portfolio. For more information please visit: www.vancestreetcapital.com.

Katie Rafferty
Business Development Manager